In order to investigate the direct effect of cholesteryl ester transfer protein (CETP) on the structure and composition of HDL in vivo, simian CETP was expressed in Fisher rat that spontaneously displays high plasma levels of HDL1. In the new CETPTg rat line, the production of active CETP by the liver induced a significant 48% decrease in plasma HDL cholesterol, resulting in a 34% decrease in total cholesterol level ( P Ͻ 0.01 in both cases). Among the various plasma HDL subpopulations, the largest HDL were those mostly affected by CETP, with a 74% decrease in HDL1 versus a significantly weaker 38% decrease in smaller HDL2 ( P Ͻ 0.0001). Apolipoprotein E (apoE)-containing HDL1 were selectively affected by CETP expression, whereas apoA content of HDL remained unmodified. The reduction in the apoE content of serum HDL observed in CETPTg rats compared to controls (53%, P Ͻ 0.02) suggests that apoE in HDL may constitute in vivo a major determinant of their ability to interact with CETP. These results bring new insight into the lack of HDL1 in plasma from CETP-deficient heterozygotes despite their substantial 50% decrease in CETP activity. In addition, they indicate that HDL1 constitute reliable and practicable sensors of very low plasma CETP activity in vivo.
Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that catalyzes an hetero-exchange of cholesteryl esters (CE) and triglycerides (TG) between HDL and apolipoprotein B (apoB) containing lipoproteins (1, 2).Over the last decade, considerable speculations have been emitted on the pro-or anti-atherogenic properties of CETP. Recently, the experimental blockade of CETP in cholesterol-fed rabbits, an animal species with elevated CETP activity and high atherosclerosis susceptibility, by the use of either antisense oligonucleotides (3, 4), chemical inhibitors (5), or vaccination (6) led to a significant decrease in the extent of atherosclerotic lesions. In the mouse, a CETP-deficient species (7), the pro-or antiatherogenic effects of the expression of high levels of human or simian CETP were dependent on the concomitant overexpression of other genes involved in plasma lipoprotein metabolism (8,9,10,11). In the Dahl hyperlipidemic and hypertensive rat, another CETP deficient species, CETP expression produced a significant rise in atherogenic lesions (12). Finally, studies in CETP-deficient patients did not clarify the point as to whether CETP is a pro-or antiatherogenic factor, depending on the population and the metabolic context studied (13).Besides its long-term effect on atherogenesis, CETP also exerts a strong and direct effect on HDL structure and composition. In this context, and from a metabolic point of view, the mouse and rabbit present some limitations, with large HDL1 particles representing only minor comAbbreviations: CETP, cholesteryl ester transfer protein; TC, total cholesterol; TG, triglycerides.